Small molecule treatment of fatty liver disease and hcc

A compound of formula (I)

• or a pharmaceutically acceptable salt thereof, wherein:
• both are single bonds or double bonds;
• X is selected from —(CH2)2— and —NR3— when is a single bond;
• X is —CH— when is a double bond;
• R1 is independently selected from a carbonyl and a sulphonyl;
• R2 is selected from the group consisting of
• R3 is selected from the group consisting of —H,
• R4 is
• M is N or CH;
• R5 is —H, halide,
• R6 is —H, -Me or phenyl;
• and
• R7 is C1-C3 alkyl or an optionally substituted aryl;
• provided that it is not a compound according to any one of formulae (II)-(V).